Opening book details…
About this Medicine article
314 POSTER Combined antitumor efficacies of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor, with other anticancer drugs by T. Tamura; S. Takagi; K. Horikoshi; T. Yusa; M. Koyama; H. Tojo; Y. Ohta is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- T. Tamura; S. Takagi; K. Horikoshi; T. Yusa; M. Koyama; H. Tojo; Y. Ohta
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2008
- Field
- Medicine (Health Sciences)
More by T. Tamura; S. Takagi; K. Horikoshi; T. Yusa; M. Koyama; H. Tojo; Y. Ohta
Browse all works by T. Tamura; S. Takagi; K. Horikoshi; T. Yusa; M. Koyama; H. Tojo; Y. Ohta